Preclinical Evaluation of [<sup>18</sup>F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

<div>Chemical structure of <b>[</b><sup><b>18</b></sup><b>F]LCATD</b>.</div>

Contrast Media & Molecular Imaging

fig1

Figure 1

Figure 1: Preclinical Evaluation of [<sup>18</sup>F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters 

Contrast Media & Molecular Imaging

Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

Figure 1

Preclinical Evaluation of [¹⁸F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters